饮食干预和口服营养补充在炎症性肠病:目前的证据和未来的方向
Brigida Barberio1,2, Luisa Bertin1,2, Sonia Facchin1,2
1Department of Surgery, Oncology, Gastroenterology, University of Padua, Via Giustiniani 2, 35121 Padua, Italy.
Nutrients
|June 13, 2025
概括
饮食干预和口服营养补充剂 (ONS) 在治疗炎症性肠病 (IBD) 中非常有价值. 研究表明,特定的饮食,如独家肠道营养 (EEN) 和克罗恩氏病.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
- 炎症性肠病 (IBD) 研究研究
- 临床营养治疗药物 临床营养治疗药物
背景情况:
- 营养管理是炎症性肠病 (IBD) 护理的关键.
- 证据支持与药理疗法一起进行饮食干预.
- 由于研究设计和终点的多样性,临床指导是分散的.
研究的目的:
- 在克罗恩病 (CD) 和性结肠炎 (UC) 中,批判性地审查饮食策略和口服营养补充剂 (ONS) 的证据.
- 强调这些干预措施的临床应用,作用机制和局限性.
- 检查ONS在IBD患者结局中的作用.
主要方法:
- 在PubMed,Scopus和Web of Science中进行全面的文献搜索.
- 对IBD治疗中各种饮食方法的研究分析.
- 包括对IBD的口服营养补充剂 (ONS) 的研究.
主要成果:
- 独家肠道营养 (EEN) 是儿科CD的第一线治疗方法.
- 部分肠道营养 (PEN) 和克罗恩病排除饮食 (CDED) 在儿童和成人中显示出有前途.
- 全食,排斥饮食和ONS为症状控制,营养不良和患者结果提供了好处.
结论:
- 饮食干预和ONS是IBD管理中的有价值的治疗工具.
- 未来的研究需要标准化试验和个性化营养.
- 将营养方法纳入全面的IBD护理途径.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Inflammatory Bowel Disease V: Surgical Management
134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
134
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145


